Cambrex Corp (NYSE:CBM)

21.04
Data as of Apr 17
 +0.08 / +0.38%
Today’s Change
11.75
Today|||52-Week Range
22.34
+18.00%
Year-to-Date
SECTOR
Process Industries
INDUSTRY
Chemicals: Specialty
MARKET CAP
$607.1M

Company Description

Cambrex Corp. is a life sciences company. It provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies its products and services worldwide to innovator and generic pharmaceutical companies. It products include active pharmaceutical ingredients (APIs) and intermediates, generic and branded APIs, controlled substances, chiral compounds, high potency and technology-enhanced APIs, and fine chemicals. The company supplies generic and branded APIs for various indications, including pain management, cardiovascular, central nervous system, endocrine, gastrointestinal, integumentary, respiratory and urinary. It sells its products directly, as well as through independent agents to various pharmaceutical and generic drug companies. Cambrex was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.

Contact Information

Cambrex Corp.
1 Meadowlands Plaza
East Rutherford New Jersey 07073
P:(201) 804-3000
Investor Relations:
(201) 804-3037

Employees

Shareholders

Other institutional51.51%
Mutual fund holders45.17%
Individual stakeholders3.72%

Top Executives

Steven M. KloskPresident, Chief Executive Officer & Director
Shawn P. CavanaghChief Operating Officer & Executive Vice President
Gregory P. SargenChief Financial Officer & Executive Vice President
Jayne MuirHead-New Technologies & Market Research
William M. HaskelSecretary, Chief Compliance Officer & Senior VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.